Eval 3-Drug Therapy Diethylcarbamize, Albendazole and Ivermectin That Could Accelerate LF Elimination Outside of Africa
Clinical trial NCT01975441 · COMPLETED
Trial details
- NCT number
- NCT01975441
- Sponsor
- University Hospitals Cleveland Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2017-12-01
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.